Chemoinformaics analysis of 8(9)-Dehydrothymol isobutyrate
| Molecular Weight | 218.296 | nRot | 3 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 8 |
| Exact Molecular Weight | 218.131 | nRing | 1 |
| Solubility: LogS | -5.276 | nHRing | 0 |
| Solubility: LogP | 4.557 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 36.9863 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.572 |
| Synth | 2.201 |
| Natural Product Likeliness | 0.143 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.01 |
| CACO-2 | -4.579 |
| MDCK | 0.0000248 |
| BBB | 0.991 |
| PPB | 0.814738 |
| VDSS | 1.218 |
| FU | 0.414007 |
| CYP1A2-inh | 0.961 |
| CYP1A2-sub | 0.835 |
| CYP2c19-inh | 0.861 |
| CYP2c19-sub | 0.723 |
| CYP2c9-inh | 0.613 |
| CYP2c9-sub | 0.809 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.578 |
| CYP3a4-inh | 0.217 |
| CYP3a4-sub | 0.391 |
| CL | 7.336 |
| T12 | 0.434 |
| hERG | 0.017 |
| Ames | 0.014 |
| ROA | 0.076 |
| SkinSen | 0.909 |
| Carcinogencity | 0.376 |
| EI | 0.87 |
| Respiratory | 0.169 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.742602 |